[HTML][HTML] Glucocorticoid therapy for acute respiratory distress syndrome: Current concepts

Y Zhao, Z Yao, S Xu, L Yao, Z Yu - Journal of Intensive Medicine, 2024 - Elsevier
Acute respiratory distress syndrome (ARDS), a fatal critical disease, is induced by various
insults. ARDS represents a major global public health burden, and the management of …

COVID-19 thromboprophylaxis. New evidence

R Ferrandis, P Sierra, A Gomez-Luque - Revista Española de …, 2024 - Elsevier
Recent publications have questioned the efficacy of using therapeutic or intermediate doses
of low molecular weight heparin (LMWH) in COVID-19 patients, especially in the most …

[HTML][HTML] Safety and Outcome of High-Flow Nasal Oxygen Therapy Outside ICU Setting in Hypoxemic Patients With COVID-19

ML Janssen, Y Türk, SJ Baart, W Hanselaar… - Critical Care …, 2024 - journals.lww.com
OBJECTIVE: High-flow nasal oxygen (HFNO) therapy is frequently applied outside ICU
setting in hypoxemic patients with COVID-19. However, safety concerns limit more …

[HTML][HTML] Predictors of in-hospital mortality in elderly unvaccinated patients during SARS-CoV-2 Alpha variants epidemic

Z Saito, S Uchiyama, S Nishioka, K Tamura… - Infection Prevention in …, 2024 - Elsevier
Background COVID-19, caused by SARS-CoV-2, has caused a global pandemic. This study
aimed to identify predictors of in-hospital mortality in unvaccinated elderly patients with …

In-hospital survival of critically ill COVID-19 patients treated with glucocorticoids: a multicenter real-world data study

S Angermair, JH Hardenberg, K Rubarth, F Balzer… - Scientific Reports, 2024 - nature.com
The COVID-19 pandemic has posed a major challenge to healthcare systems globally.
Millions of people have been infected, and millions of deaths have been reported worldwide …

Characteristics and outcomes of COVID-19 patients admitted to hospital with and without respiratory symptoms

BW Citarella, C Kartsonaki, ED Ibánez-Prada… - Heliyon, 2024 - cell.com
Background COVID-19 is primarily known as a respiratory illness; however, many patients
present to hospital without respiratory symptoms. The association between non-respiratory …

SFX-01 in hospitalised patients with community-acquired pneumonia during the COVID-19 pandemic: a double-blind, randomised, placebo-controlled trial

MB Long, H Abo-Leyah, YH Giam… - ERJ Open …, 2024 - Eur Respiratory Soc
Introduction Sulforaphane can induce the transcription factor, Nrf2, promoting antioxidant
and anti-inflammatory responses. In this study, hospitalised patients with community …

K-means clustering identifies diverse clinical phenotypes in COVID-19 patients: implications for mortality risks and remdesivir impact

C Garcia-Vidal, C Teijón-Lumbreras, TF Aiello… - Infectious Diseases and …, 2024 - Springer
Introduction The impact of remdesivir on mortality in patients with COVID-19 is still
controversial. We aimed to identify clinical phenotype clusters of COVID-19 hospitalized …

The role of technology in entrepreneurship: a comprehensive systematic and bibliometric analysis

UR Jayanna, SK Jaya Prakash, R Aluvala… - Kybernetes, 2024 - emerald.com
Purpose Through bibliometric analysis, the study intends to reveal the evolution of the trends
in the Scopus database, the scope of research and the connection between technology and …

A worldwide look into Long COVID-19 management: an END-COVID survey

M Nigro, C Valenzuela, F Arancibia… - ERJ Open …, 2024 - Eur Respiratory Soc
Background Long COVID is a heterogeneous clinical syndrome characterised by a variety of
reported symptoms and signs. Its clinical management is expected to differ significantly …